As of late, it has definitely been a great time to be an investor in Bio-Reference Laboratories Inc. (BRLI). The stock has moved higher by 11.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
We certainly think that this might be the case, particularly if you consider BRLI’s recent earnings estimate revision activity. On Dec 18, the company reported strong fourth quarter earnings per share. From this look, the company’s future is quite favorable; as BRLI has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment